Edition:
United Kingdom

HLS Therapeutics Q4 2018 Revenue Was $16.7 Mln Compared To $20.4 Mln In Q4 2017


Thursday, 21 Mar 2019 

March 21 (Reuters) - HLS Therapeutics Inc ::HLS THERAPEUTICS ANNOUNCES Q4 AND YEAR-END 2018 FINANCIAL RESULTS.Q4 2018 REVENUE WAS $16.7 MILLION COMPARED TO $20.4 MILLION IN Q4 2017.Q4 2018 NET INCOME OF $0.4 MILLION, OR $0.01 PER COMMON SHARE.Q4 2018 ADJUSTED EBITDA WAS $11.2 MILLION COMPARED TO $15.5 MILLION IN Q4 2017. 

Company Quote

16.51
0.01 +0.06%
6:18pm BST